The biopharmaceutical excipients market is on the brink of substantial expansion, projected to reach a remarkable USD 12.4 billion by 2035. This growth reflects an impressive compound annual growth rate (CAGR) of 5.09% from its anticipated 2024 value of USD 7.18 billion. As the demand for advanced drug formulations accelerates, particularly in North America, this sector is becoming increasingly...